COVID-19 Antibody Testing
COVID-19 Antibody Testing
Testing can be authorized by our Physicians When:
+ If you had symptoms, and want to know whether it was COVID-19
+ If you are asymptomatic, but may have potentially been exposed (close or proximate contact with a person known to be positive with COVID-19
+ Individuals subject to precautionary or mandatory quarantine
+ Individuals employed as a health care worker, first responder, or essential workers who directly interacts with the public
+ Individuals present with a case where facts and circumstances warrant testing as determined by clinician or health officials
+ If you tested Positive for COVID-19 via Nasal Swab PCR – and want to see if you have produced antibodies that can be detected
Who Should Not Take This Test?
+ If you are actively having symptoms. Seek medical attention right away if you are experiencing severe symptoms
+ If you had symptoms, please wait at least 7-10 days to take the test counting from the START of your symptoms. Sensitivity is higher 15-20 days onwards. Antibodies take time to develop – taking the test too early may not give accurate results.
Click here to read more:
Please refer to the WHO Statement on Antibodies and Immunity.
This following article also contains some good information:
We are offering a limited amount of testing to our patients on a sign-up list. To enroll in our study please sign up.
FAQsIf you have any questions or concerns that are not addressed below, please email us at firstname.lastname@example.org.
This COVID-19 IgM/IgG Rapid Test is being made available under Emergency Use Authorization, per guidance issued by the U.S. Food and Drug Administration (FDA) titled “Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency,” which was issued on March 16, 2020. FDA issued this guidance to help accelerate the availability of novel coronavirus (COVID-19) diagnostic tests developed by laboratories and commercial manufacturers during the public health emergency. These tests have not been reviewed by the FDA.
The detection of antibodies in blood serum can help assess the likelihood of past as well as present infection, and are meant to be used as an aid to health care professionals in diagnosing the mid- to later stages of the viral infection. Along with other information, such as the presence of symptoms, the tests may help health care professionals assess whether individuals (including health care workers) have recovered from the virus. Follow-up testing with a molecular diagnostic should be considered to confirm or rule out infection.
If you test positive for the antibodies, please consider contacting a blood bank or hospital to donate blood. New York City hospitals have started isolating blood plasma (where all the antibodies are contained) from patients who are immune to COVID-19. The plasma is then transferred to critically ill patients to boost their immune systems, to help them fight against the infection.
Please refer to your local guidelines on Return to Work or Release from Home Isolation protocols.